| 國立交通大學 |
2022-02-23T01:31:27Z |
【活動花絮】學術國際化經驗分享
|
高儷玲 |
| 國立交通大學 |
2022-02-23T01:31:27Z |
【活動花絮】參與國際會議 鍛鍊學術英文
|
林珮雯 |
| 國立交通大學 |
2022-02-23T01:31:28Z |
【活動花絮】資工系首推英語學術能力課程 提升國際競爭力
|
劉美君/資工系英語助教 |
| 國立交通大學 |
2022-02-23T01:31:28Z |
【活動花絮】CGI Lab 團隊再創佳績！抱走 AWS DeepRacer 世界冠軍
|
高儷玲 |
| 國立交通大學 |
2022-02-23T01:31:28Z |
【活動花絮】CS+X 跨界合作 2020 交大物聯網科技藝術節
|
高儷玲 |
| 國立交通大學 |
2022-02-23T01:31:28Z |
【院系消息】
|
Anonymous |
| 國立交通大學 |
2022-02-23T01:31:28Z |
【募款計畫】
|
Anonymous |
| 國立交通大學 |
2022-02-23T01:31:28Z |
【院長的話】提升國際影響力
|
陳志成 |
| 國立交通大學 |
2022-02-23T01:31:28Z |
【產學合作】醫療領域未來之星 智慧醫療 iDeepCare
|
高儷玲 |
| 國立交通大學 |
2022-02-23T01:31:28Z |
【產學合作】「溫」故知新 ：台灣研究團隊打造 AIoT 智能溫控新時代
|
科技部 |
| 國立交通大學 |
2022-02-23T01:31:29Z |
【活動花絮】學生用專業回饋社會 架網站關懷社會議題
|
林珮雯 |
| 國立交通大學 |
2022-02-23T01:31:29Z |
【教師專訪】謝秉均老師：持續探索 找到自己喜歡又擅長的事
|
高儷玲 |
| 國立交通大學 |
2022-02-23T01:31:29Z |
【科普軼聞】量子計算的源頭 - 波爾叔叔
|
林一平/講座教授 |
| 國立交通大學 |
2022-02-23T01:31:29Z |
【資訊系友】【系學會全新企劃 X 誰來晚餐】吳銘雄 － 驚奇有趣才是人生！
|
范瑀真 |
| 國立交通大學 |
2022-02-23T01:31:29Z |
【科普軼聞】三位女性密碼專家
|
林一平/講座教授 |
| 臺大學術典藏 |
2022-02-23T02:12:17Z |
Tenofovir Is Superior to Entecavir on Tertiary Prevention for BCLC Stage 0/A Hepatocellular Carcinoma after Curative Resection
|
Tsai M.-C.; Wang C.-C.; Lee W.-C.; Lin C.-C.; Chang K.-C.; CHIEN-HUNG CHEN; Hung C.-H.; Lin M.-T.; Hsiao C.-C.; Chen C.-L.; Chien R.-N.; Hu T.-H. |
| 臺大學術典藏 |
2022-02-23T02:12:18Z |
Incidences and Determinants of Functional Cure During Entecavir or Tenofovir Disoproxil Fumarate for Chronic Hepatitis B
|
Hsu Y.-C.; Yeh M.-L.; Wong G.L.-H.; CHIEN-HUNG CHEN; Peng C.-Y.; Buti M.; Enomoto M.; Xie Q.; Trinh H.; Preda C.; Liu L.; Cheung K.-S.; Yeo Y.H.; Hoang J.; Huang C.-F.; Riveiro-Barciela M.; Kozuka R.; Istratescu D.; Tsai P.-C.; Accarino E.V.; Lee D.-H.; Wu J.-L.; Huang J.F.; Dai C.-Y.; Cheung R.; Chuang W.-L.; Yuen M.-F.; Wong V.W.-S.; Yu M.-L.; Nguyen M.H. |
| 臺大學術典藏 |
2022-02-23T02:12:18Z |
Corrigendum: Real-World Lenvatinib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis (Front. Oncol., (2021), 11, (737767), 10.3389/fonc.2021.737767)
|
Kuo Y.-H.; Lu S.-N.; Chen Y.-Y.; Kee K.-M.; Yen Y.-H.; Hung C.-H.; Hu T.-H.; CHIEN-HUNG CHEN; Wang J.-H. |
| 臺大學術典藏 |
2022-02-23T02:12:18Z |
Real-World Lenvatinib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis
|
Kuo Y.-H.; Lu S.-N.; Chen Y.-Y.; Kee K.-M.; Yen Y.-H.; Hung C.-H.; Hu T.-H.; CHIEN-HUNG CHEN; Wang J.-H. |
| 臺大學術典藏 |
2022-02-23T02:12:19Z |
Limited predictive or prognostic role of tumor-infiltrating tissue-resident memory cd8 t cells in patients with hepatocellular carcinoma receiving immunotherapy
|
Shen Y.-C.; Yeh C.-P.; Jeng Y.-M.; Hsu C.; Hsu C.-H.; Lin Z.-Z.; Shao Y.-Y.; Lu L.-C.; Liu T.-H.; CHIEN-HUNG CHEN; Cheng A.-L. |
| 臺大學術典藏 |
2022-02-23T02:12:19Z |
How may ramucirumab help improve treatment outcome for patients with gastrointestinal cancers?
|
Chen M.-H.; Lu S.-N.; CHIEN-HUNG CHEN; Lin P.-C.; Jiang J.-K.; D’yachkova Y.; Lukanowski M.; Cheng R.; Chen L.-T. |
| 臺大學術典藏 |
2022-02-23T02:12:19Z |
Long-term effectiveness of population-wide multifaceted interventions for hepatocellular carcinoma in Taiwan
|
Liao S.-H.; Chen C.-L.; Hsu C.-Y.; Chien K.-L.; Kao J.-H.; Chen P.-J.; Chen T.H.-H.; CHIEN-HUNG CHEN |
| 臺大學術典藏 |
2022-02-23T02:12:20Z |
Management consensus guideline for hepatocellular carcinoma: 2020 update on surveillance, diagnosis, and systemic treatment by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan
|
Shao Y.-Y.; Wang S.-Y.; Lin S.-M.; Chen K.-Y.; Tseng J.-H.; Ho M.-C.; Lee R.-C.; Liang P.-C.; Liao L.-Y.; Huang K.-W.; Hu J.-T.; Liang J.-D.; Kee K.-M.; Lin C.-L.; Wang C.-K.; Lu S.-N.; Wang J.-H.; Lee W.-C.; CHIEN-HUNG CHEN; Liu C.-J.; Huang Y.-H.; Wang C.-C.; Wang T.-E.; Chuang P.-H.; Dai C.-Y.; Hsu C.; Chen S.-C.; Hsieh C.-H.; Diagnosis Group, Systemic Therapy Group |
| 臺大學術典藏 |
2022-02-23T02:12:20Z |
Hepatocellular Carcinoma With Pleural Metastases Without Residual Liver Tumor Diagnosed by Pleuroscopy [Carcinoma hepatocelular con metástasis pleurales y sin tumor hepático residual diagnosticado mediante pleuroscopía]
|
Kuo C.-C.; Chen C.-Y.; CHIEN-HUNG CHEN |
| 臺大學術典藏 |
2022-02-23T02:12:20Z |
Morgagni hernia causing ileus and gastric emphysema
|
Lee J.-Y.; CHIEN-HUNG CHEN |
| 臺大學術典藏 |
2022-02-23T02:12:21Z |
Sofosbuvir/Velpatasvir for Hepatitis C Virus Infection: Real-World Effectiveness and Safety from a Nationwide Registry in Taiwan
|
Cheng P.-N.; Mo L.-R.; Chen C.-T.; Chen C.-Y.; Huang C.-F.; Kuo H.-T.; Lo C.-C.; Tseng K.-C.; Huang Y.-H.; Tai C.-M.; Peng C.-Y.; Bair M.-J.; CHIEN-HUNG CHEN; Yeh M.-L.; Lin C.-L.; Lin C.-Y.; Lee P.-L.; Chong L.-W.; Hung C.-H.; Chang T.S.; Huang J.-F.; Yang C.-C.; Hu J.-T.; Lin C.-W.; Wang C.-C.; Su W.-W.; Hsieh T.-Y.; Lin C.-L.; Tsai W.-L.; Lee T.-H.; Chen G.-Y.; Wang S.-J.; Chang C.-C.; Yang S.-S.; Wu W.-C.; Huang C.-S.; Chou K.-H.; Kao C.-N.; Tsai P.-C.; Liu C.-H.; Lee M.-H.; Cheng C.-Y.; Tsai M.-C.; Liu C.-J.; Dai C.-Y.; Lin H.-C.; Kao J.-H.; Chuang W.-L.; Yu M.-L.; TACR investigators |
| 臺大學術典藏 |
2022-02-23T02:12:21Z |
Liver stiffness-based score at sustained virologic response predicts liver-related complications after eradication of hepatitis C virus
|
Kuo Y.-H.; Kee K.-M.; Hung C.-H.; Lu S.-N.; Hu T.-H.; CHIEN-HUNG CHEN; Wang J.-H. |
| 臺大學術典藏 |
2022-02-23T02:12:21Z |
Chronic hepatitis B exhibited higher rate of hepatocellular carcinoma occurrence than hepatitis C in cirrhotic patients after effective antiviral treatment
|
Lin M.-T.; Chang K.-C.; Yen Y.-H.; Tsai M.-C.; CHIEN-HUNG CHEN; Wang J.-H.; Hsiao C.-C.; Chiu Y.-H.; Hu T.-H. |
| 臺大學術典藏 |
2022-02-23T02:12:22Z |
Microelimination of chronic hepatitis C by universal screening plus direct-acting antivirals for incarcerated persons in Taiwan
|
Yang T.-H.; Fang Y.-J.; Hsu S.-J.; Lee J.-Y.; Chiu M.-C.; Yu J.-J.; Kuo C.-C.; CHIEN-HUNG CHEN |
| 臺大學術典藏 |
2022-02-23T02:12:22Z |
Use of glecaprevir/pibrentasvir in patients with chronic hepatitis c virus infection and severe renal impairment
|
Yap D.Y.H.; Liu K.S.H.; Hsu Y.-C.; Wong G.L.H.; Tsai M.-C.; CHIEN-HUNG CHEN; Hsu C.-S.; Hui Y.T.; Li M.K.K.; Liu C.-H.; Kan Y.-M.; Yu M.-L.; Yuen M.-F. |
| 臺大學術典藏 |
2022-02-23T02:12:22Z |
Real-world effectiveness of glecaprevir/pibrentasvir and ledipasvir/sofosbuvir for mixed genotype hepatitis C infection: A multicenter pooled analysis in Taiwan
|
Chiu W.-N.; Hung C.-H.; Lu S.-N.; Chen M.-Y.; Tung S.-Y.; Wei K.-L.; Lu C.-K.; CHIEN-HUNG CHEN; Hu T.-H.; Hu J.-H.; Chen W.-M.; Chang T.-S. |
| 臺大學術典藏 |
2022-02-23T02:12:23Z |
Hepatitis C virus core antigen is cost-effective in community-based screening of active hepatitis C infection in Taiwan
|
Wang J.-H.; CHIEN-HUNG CHEN; Chang C.-M.; Feng W.-C.; Lee C.-Y.; Lu S.-N. |
| 臺大學術典藏 |
2022-02-23T02:12:23Z |
Clinical Manifestations and Outcomes of Patients with Sarcomatoid Hepatocellular Carcinoma
|
Liao S.-H.; Su T.-H.; Jeng Y.-M.; Liang P.-C.; Chen D.-S.; CHIEN-HUNG CHEN; Kao J.-H. |
| 臺大學術典藏 |
2022-02-23T02:12:23Z |
Real-world effectiveness and safety of glecaprevir/pibrentasvir in Asian patients with chronic hepatitis C
|
Hsu S.-J.; Chiu M.-C.; Fang Y.-J.; Yang T.-H.; Yu J.-J.; Chen C.-C.; Kuo C.-C.; Lee J.-Y.; CHIEN-HUNG CHEN; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2022-02-23T02:12:23Z |
Adoptive donor immunity protects against resolved hepatitis B virus reactivation after allogeneic haematopoietic stem cell transplantation in the world's largest retrospective cohort study
|
Liu J.-H.; Liao X.-W.; CHIEN-HUNG CHEN; Yao M.; Li C.-C.; Lin C.-T.; Tsai C.-H.; Chou W.-C.; Hou H.-A.; Huang S.-Y.; Wu S.-J.; Chen Y.-C.; Tien H.-F.; Tang J.-L.; Ko B.-S. |
| 臺大學術典藏 |
2022-02-23T02:12:24Z |
Current efficacy and prospectives of oral direct-acting antiviral drugs to treat chronic hepatitis c
|
Lo C.-C.; Chen M.-T.; Huang K.-C.; Lin C.-H.; Cheng H.-S.; Liao Y.-T.; Hung L.-W.; Lu S.-N.; CHIEN-HUNG CHEN |
| 臺大學術典藏 |
2022-02-23T02:12:24Z |
Multidisciplinary Taiwan consensus recommendations for the use of DEBDOX-TACE in hepatocellular carcinoma treatment
|
Chang P.-Y.; Huang C.-C.; Hung C.-H.; Yu C.-Y.; Wu D.-K.; Hwang J.-I.; Liang P.-C.; Wu R.-H.; Tsai W.-L.; Lin Y.-J.; Liu Y.-S.; Liang H.-L.; Lee R.-C.; CHIEN-HUNG CHEN |
| 臺大學術典藏 |
2022-02-23T02:12:24Z |
Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan
|
Lu S.-N.; Wang J.-H.; Su C.-W.; Wang T.-E.; Dai C.-Y.; CHIEN-HUNG CHEN; Chen R.-C.; Yang S.-S.; Hung C.-F.; Huang S.-F.; Liao L.-Y.; Huo T.-I.; Wu C.-C.; Lee P.-H.; Ting C.-T.; Lee W.-C.; Chau G.-Y.; Wang C.-C.; Lee K.-T.; Huang Y.-H.; Ho M.-C.; Lin S.-M.; Huang G.-T.; Chen K.-Y.; Lin X.-Z.; Hwang J.-I.; Chiou Y.-Y.; Wang C.-K.; Hu J.-T.; Chen S.-C.; Liang P.-C.; Lee R.-C.; Wu D.-K.; Lin C.-Y.; Lin C.-C.; Cheng A.-L.; Hsu C.; Chao Y.; Chen L.-T.; Wang P.-M.; Wang P.-M.; Hong J.-H.; Hsu H.-C.; Chen S.-W.; Leung S.W.; Cheng J.C.-H.; Wu J.-C.; Wu C.-Y.; Hsu Y.-C.; Hsu C.-W.; Ni Y.-H.; Lin C.-L.; Local ablation group, Surveillance group, Diagnosis group, Staging group, Surgery group, TACE/TARE/HAI group, Target therapy/systemic therapy group, Radiotherapy group, Prevention group, Drafting group |
| 臺大學術典藏 |
2022-02-23T02:12:24Z |
Change of Uncertainty in Illness and Unmet Care Needs in Patients with Recurrent Hepatocellular Carcinoma during Active Treatment
|
Shun S.-C.; Chou Y.-J.; CHIEN-HUNG CHEN; Yang J.-C. |
| 臺大學術典藏 |
2022-02-23T02:12:25Z |
Abdominoscrotal hydrocele
|
Liu K.-L.; Shih I.-L.; Huang Y.-C.; CHIEN-HUNG CHEN |
| 臺大學術典藏 |
2022-02-23T02:12:25Z |
Dietary choline and folate relationships with serum hepatic inflammatory injury markers in Taiwanese adults
|
Cheng C.-P.; CHIEN-HUNG CHEN; Kuo C.-S.; Kuo H.-T.; Huang K.-T.; Shen Y.-L.; Chang C.-H.; Huang R.-F.S. |
| 臺大學術典藏 |
2022-02-23T02:12:25Z |
The role of age in change in unmet supportive care needs in hepatocellular carcinoma patients during transition from hospital to home
|
Shun S.-C.; Lai Y.-H.; Hung H.; CHIEN-HUNG CHEN; Liang J.-D.; Chou Y.-J. |
| 臺大學術典藏 |
2022-02-23T02:12:26Z |
Consensus development from the 5th asia-pacific primary liver cancer expert meeting (APPLE 2014)
|
Hsu C.; Chen B.-B.; CHIEN-HUNG CHEN; Ho M.-C.; Cheng J.C.-H.; Kokudo N.; Murakami T.; Yeo W.; Seong J.; Jia J.-D.; Han K.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2022-02-23T02:12:26Z |
Hepatitis B and C viruses are not risks for pancreatic adenocarcinoma
|
Chang M.-C.; CHIEN-HUNG CHEN; Liang J.-D.; Tien Y.-W.; Hsu C.; Wong J.-M.; Chang Y.-T. |
| 臺大學術典藏 |
2022-02-23T02:12:26Z |
Up-regulation of MicroRNA-190b plays a role for decreased IGF-1 that induces insulin resistance in human hepatocellular carcinoma
|
Hung T.-M.; Ho C.-M.; Liu Y.-C.; Lee J.-L.; Liao Y.-R.; Wu Y.-M.; Ho M.-C.; CHIEN-HUNG CHEN; Lai H.-S.; Lee P.-H. |
| 臺大學術典藏 |
2022-02-23T02:12:26Z |
Interrelationships among genetic C677T polymorphism of 5,10-methylenetetrahydrofolate reductase, biochemical folate status, and lymphocytic p53 oxidative damage in association with tumor malignancy and survivals of patients with hepatocellular carcinoma
|
Kuo C.-S.; Huang C.-Y.; Kuo H.-T.; Cheng C.-P.; CHIEN-HUNG CHEN; Lu C.-L.; Yang F.-L.; Syu Huang R.-F. |
| 臺大學術典藏 |
2022-02-23T02:12:27Z |
Autoantibody recognition of an N-terminal epitope of hnRNP L marks the risk for developing HBV-related hepatocellular carcinoma
|
Yau W.-Y.; Shih H.-C.; Tsai M.-H.; Sheu J.-C.; CHIEN-HUNG CHEN; Chow L.-P. |
| 臺大學術典藏 |
2022-02-23T02:12:27Z |
Elevated preoperative serum ca19-9 levels in patients with hepatocellular carcinoma is associated with poor prognosis after resection
|
Chen Y.-L.; CHIEN-HUNG CHEN; Hu R.-H.; Ho M.-C.; Jeng Y.-M. |
| 臺大學術典藏 |
2022-02-23T02:12:27Z |
Comparison of characteristics and transarterial chemoembolization outcomes in patients with unresectable hepatocellular carcinoma and different viral etiologies
|
Chen B.-B.; Shih I.-L.; Wu C.-H.; Hsu C.; CHIEN-HUNG CHEN; Shih T.T.-F.; Liu K.-L.; Liang P.-C. |
| 臺大學術典藏 |
2022-02-23T02:12:27Z |
Validating and improving the reliability of the EORTC QLQ-C30 using a multidimensional rasch model
|
Shih C.-L.; CHIEN-HUNG CHEN; Sheu C.-F.; Lang H.-C.; Hsieh C.-L. |
